For an integer k ≥ 2, let (F (k) n )n be the k−Fibonacci sequence which starts with 0, . . . , 0, 1 (k terms) and each term afterwards is the sum of the k preceding terms.In this paper, we search for powers of 2 which are sums of two k−Fibonacci numbers.The main tools used in this work are lower bounds for linear forms in logarithms and a version of the Baker-Davenport reduction method in diophantine approximation. This paper continues and extends the previous work of [3] and [6].
For an integer k ≥ 2, let (L (k) n )n be the k−generalized Lucas sequence which starts with 0, . . . , 0, 2, 1 (k terms) and each term afterwards is the sum of the k preceding terms. In this paper, we find all the integers that appear in different generalized Lucas sequences; i.e., we study the Diophantine equation L (k) n = L (ℓ) m in nonnegative integers n, k, m, ℓ with k, ℓ ≥ 2. The proof of our main theorem uses lower bounds for linear forms in logarithms of algebraic numbers and a version of the Baker-Davenport reduction method. This paper is a continuation of the earlier work [4].Keywords and phrases. Generalized Fibonacci and Lucas numbers, lower bounds for nonzero linear forms in logarithms of algebraic numbers, reduction method.
Let φ denote Euler's phi function. For a fixed odd prime q we investigate the first and second order terms of the asymptotic series expansion for the number of n x such that q ∤ φ(n). Part of the analysis involves a careful study of the Euler-Kronecker constants for cyclotomic fields. In particular, we show that the Hardy-Littlewood conjecture about counts of prime k-tuples and a conjecture of Ihara about the distribution of these Euler-Kronecker constants cannot be both true.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.